Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/26/2012US20120189554 Multi-functional drug carriers
07/26/2012US20120189552 Compositions and methods using microspheres and non-ionic contrast agents
07/26/2012US20120189550 Orally administered bacteria as vehicles for systematic delivery of agents
07/26/2012US20120189541 Dual Variable Domain Immunnoglobulins and Uses Thereof
07/26/2012US20120189540 IL3Ralpha Antibody Conjugates And Uses Thereof
07/26/2012US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/26/2012US20120189537 Nitrile derivatives and their pharmaceutical use and compositions
07/26/2012CA2824997A1 Compositions and methods for treating cancer
07/26/2012CA2824925A1 Quinazolinone inhibitors of dynein
07/26/2012CA2824873A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012CA2824871A1 Bicyclic inhibitors of alk
07/26/2012CA2824689A1 Combination therapy for cancer
07/26/2012CA2824544A1 Picolinamide inhibitors of kinases
07/26/2012CA2824332A1 Bicyclic inhibitors of alk
07/26/2012CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012CA2816093A1 Compounds and compositions for the treatment of cancer
07/25/2012EP2479276A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479275A1 HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
07/25/2012EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
07/25/2012EP2478907A2 Methods and compositions for treating cancer
07/25/2012EP2478905A2 Treatment of imatinib resistant leukemia using 4-aminoquinoline-3-carbonitriles
07/25/2012EP2478904A1 A pharmaceutical composition for peroral administration of diindolylmethane
07/25/2012EP2478899A1 Composition for alleviating ultraviolet radiation-induced damage
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477988A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
07/25/2012EP2477975A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same
07/25/2012EP2477972A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases
07/25/2012EP2477700A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
07/25/2012EP2477699A1 Medical use of spla2 hydrolysable liposomes
07/25/2012EP2477655A2 Vaccines directed to langerhans cells
07/25/2012EP2477653A1 Dosage regimen for administering an epcamxcd3 bispecific antibody
07/25/2012EP2477641A2 Inhibition of endosomal toll-like receptor activation
07/25/2012EP2477635A2 Methods for treating brain tumors
07/25/2012EP2477632A1 Pharmaceutical combination for treating tumor
07/25/2012EP2477625A2 Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
07/25/2012EP2477496A1 Novel compounds and therapeutic use thereof for protein kinase inhibition
07/25/2012EP2131867B1 Modified hydroxypolymer conjugates with killing effect on tumor cells
07/25/2012EP2089401B1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries
07/25/2012EP2018170B1 Medication against breast cancer
07/25/2012EP2007774B1 Thiazolyldihydroindazole derivatives as protein kinase inhibitors
07/25/2012EP1684780B1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
07/25/2012EP1592457B1 Folate-vinblastine conjugate as medicament
07/25/2012EP1501921B2 Improved viral purification methods
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/25/2012EP1252162B1 Alpha v integrin receptor antagonists
07/25/2012EP0800829B2 Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin
07/25/2012CN1872334B Slow releasing microsphere preparation of Thymopentin, and preparation method
07/25/2012CN1653183B Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/25/2012CN102612524A Dual variable domain immunoglobulins and uses thereof
07/25/2012CN102612516A Substituted pyrrolidine-2-carboxamides
07/25/2012CN102612369A Anti-tumor effect potentiator
07/25/2012CN102612368A Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity
07/25/2012CN102612365A Checkpoint kinase 1 inhibitors for potentiating DNA damaging agents
07/25/2012CN102604992A Method for constructing recombinant adenovirus by utilizing TRAIL and HN genes as well as recombinant adenovirus and application
07/25/2012CN102604970A Preparation method and application of medoggreenpit-viper venom L-amino acid oxidase
07/25/2012CN102604952A miRNA molecule and application thereof
07/25/2012CN102604949A Anaerobic tissue selective gene expression method driven by alcohol dehydrogenase promoter and application thereof
07/25/2012CN102604946A Small interfering ribonucleic acid (siRNA) for inhibiting tumor metastasis and application thereof
07/25/2012CN102604855A Bifidobacterium longum SQS7-31, as well as preparation method and application thereof
07/25/2012CN102604083A Polymer modified lipid material and application thereof
07/25/2012CN102604082A Cis-platinum coordination compound and preparation method thereof
07/25/2012CN102603911A Corbicula fluminea glycosaminoglycan and preparation method and usage thereof
07/25/2012CN102603909A Laminarin with antioxidation and antineoplastic activity and extracting-separating method of laminarin
07/25/2012CN102603897A Fusion protein containing guide peptide and GnRH-PE39KDEL as well as nucleic acid and application thereof
07/25/2012CN102603887A IL-24 (interleukin-24) polypeptide with tumor resistance and application thereof
07/25/2012CN102603884A Diamond back moth antibacterial peptide and preparation method and application thereof
07/25/2012CN102603858A Azacycle-containing derivative of betulinol, preparation method thereof, and purpose thereof
07/25/2012CN102603856A Anti-tumor saponin in anemone plants and preparation method thereof as well as application
07/25/2012CN102603849A Gynostemma pentaphylla secondary saponin, preparation method and applications thereof
07/25/2012CN102603848A Preparation method of ginsenoside Rh2 fatty acid diester, and medicinal use of the ginsenoside Rh2 fatty acid diester
07/25/2012CN102603847A Preparation method and medicinal application of ginsenoside Rh2 aliphatic ester compound
07/25/2012CN102603826A Method for extracting 8-acetylharpagide from decumbent bugle herb plant
07/25/2012CN102603824A New 3'-azido daunorubicin-13-thiosemicarbazone compound with cancer resistance and preparation method thereof
07/25/2012CN102603812A Binuclear platinum (II)-zoledronate complex and preparation and application thereof
07/25/2012CN102603805A Platinum (II) complex with antineoplastic activity and preparation method of platinum (II) complex
07/25/2012CN102603804A Novel platinum complex, preparation method and applications of platinum complex
07/25/2012CN102603783A Targeted malignant tumor resistance medicament and preparation method thereof
07/25/2012CN102603769A Sulfur-containing chromone compound and preparation method thereof and application in preparation of antitumor drugs
07/25/2012CN102603766A Preparation method and application of tamoxifen twin drug
07/25/2012CN102603765A Method for extracting active ingredients of Euphorbia fischeriana and diterpenoid medicament prepared by active ingredients
07/25/2012CN102603763A Method for extracting lignans compounds from Radix Clematidis and application
07/25/2012CN102603761A Etoposide compound with hydroxamic acid structure and preparation method and usage thereof
07/25/2012CN102603759A Camptothecin E ring analogues and applications thereof as drugs
07/25/2012CN102603753A Isomers of hemoporfin
07/25/2012CN102603743A Anti-tumor benzazepine[f]azulene derivative, preparation method thereof, and purpose thereof
07/25/2012CN102603737A Pyridopyrimidine ketones derivative and application in preparing antitumor drugs thereof
07/25/2012CN102603734A Protein kinase inhibitor and application thereof
07/25/2012CN102603729A N-(2-(substituted benzothiazole-2-formamyl)-substituted phenyl) pyridine carboxamide derivative
07/25/2012CN102603728A 4-alkyl-2-aryl amino-5-(1,2,4-triazol-1-yl)thiazole and preparation method and application thereof
07/25/2012CN102603727A Synthetic method of benzothiazole derivative
07/25/2012CN102603717A Pyrrylketone compound and application thereof as drug
07/25/2012CN102603712A S-type and R-type tetrahydro-naphthalene amides antitumor compound and pharmaceutically acceptable salt or pro-drug thereof, preparation method and application
07/25/2012CN102603692A Chroman and chromene derivatives as tumor multidrug resistance inhibitor as well as preparation method and application of chroman and chromene derivatives
07/25/2012CN102603689A Norditerpenoid compound Lachnin A, and preparation method and application thereof
07/25/2012CN102603677A Curcumin-4-mannich base derivative, preparation method and use of curcumin-4-mannich base derivative
07/25/2012CN102603667A N-(2-chloro-6-methyl phenyl)-2-(phenyl acrylamide)thiazole-5-formamide derivative, and preparation method and use thereof
07/25/2012CN102603642A Nickel-containing sandwich polyoxometallate anti-cancer drug and synthesis method thereof
07/25/2012CN102603637A Pyrazol compound and purpose of pyrazol compound used as receptor tyrosine kinases (RTK) and phosphatidyl inositol 3-kinase (PI3K) dual inhibitors
07/25/2012CN102603635A Derivatives of geldanamycin, as well as preparation method and application thereof